Interv Akut Kardiol. 2016;15(3):135-139 | DOI: 10.36290/kar.2016.027

Suboptimal stent apposition - treat or leave it?

Tomáš Kovárník1, Karel Kopřiva2, Štěpán Jeřábek1
1 II. interní klinika kardiologie a angiologie VFN v Praze a 1. LF UK, Praha
2 Kardiologické oddělení nemocnice Na Homolce, Praha

Authors bring an overview of actual knowledge concerning inadequate stent apposition, its causes, possibilities of diagnosis and

potential consequences. Main attention is dedicated to techniques of stent malapposition diagnosis. Recommendations are given

how to decrease the occurrence of this complication.

Keywords: optical coherence tomography, stent apposition, in stent thrombosis

Published: October 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kovárník T, Kopřiva K, Jeřábek Š. Suboptimal stent apposition - treat or leave it? Interv Akut Kardiol. 2016;15(3):135-139. doi: 10.36290/kar.2016.027.
Download citation

References

  1. Mintz GS, Nissen SE, Anderson WD, Bailey SR, Erbel R, Fitzgerald PJ, Pinto FJ, Rosenfield K, Siegel RJ, Tuzcu EM, Yock PG. American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents J Am Coll Cardiol 2001; 37: 1478-1492.
  2. de Ribamar Costa J Jr, Mintz GS, Carlier SG, Costa RA, Fujii K, Sano K, Kimura M, Lui J, Weisz G, Moussa I, Dangas G, Mehran R, Lansky AJ, Kreps EM, Collins M, Stone GW, Moses JW, Leon MB. Intravascular ultrasonic assessment of stent diameters derived from manufacturer's compliance charts. Am J Cardiol 2005; 96: 74-78. Go to original source... Go to PubMed...
  3. Bermejo J, Botas J, García E, Elízaga J, Osende J, Soriano J, Abeytua M, Delcán JL. Mechanism of residual lumen stenosis after high-pressure stent implantation. A quantitative coronary angiography and intravascular ultrasound study. Circulation 1998; 98: 112-118. Go to original source... Go to PubMed...
  4. Mintz GS. What to do about late incomplete stent apposition? Circulation 2007; 115: 2379-2381. Go to original source... Go to PubMed...
  5. Foin N, Gutierrez-Chico JL, Nakatani S, Torii R, Bourantas CV, Sen S, Nijjer S, Petraco R, Kousera C, Ghione M, Onuma Y, Garcia-Garcia HM, Francis PD, Wong P, Di Mario C, Davies JE, and Serruys PW. Incomplete stent apposition causes high shear flow disturbances and delay in neointimal coverage as a function of strut to wall detachment distance: implications for the management of incomplete stent apposition. Circ. Cardiovasc.Interv. 2014; 7: 180-189. Go to original source... Go to PubMed...
  6. Virmani R, Guagliumi G, Farb A, Nusumeci G, Grieco N, Motta T, Mihalcsik L, Tespili M, Valsecchi O, Kolodgie FD. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stents: should we be cautious ? Circulation 2004; 109: 701-705. Go to original source... Go to PubMed...
  7. Hong MK, Mintz GS, Lee ChW, Park DW, Park KM, Lere BK, Kim YH, Song JM, Han KH, Kang DH, Cheong SS, Song JK, Kim JJ, Park SW, Park SJ. Late stent malpposition after drug-eluting stent implantation: an intravascular ultrasound analysis with long-term follow-up. Circulation 2006; 113: 414-419. Go to original source... Go to PubMed...
  8. Tada T, Kadota K, Hosogi S, Kubo S, Ozaki M, Yoshino M, Miyake K, Eguchi H, Ohashi N, Hayakawa Y, Saito N, Otsuru S, Hasegawa D, Shigemoto Y, Habara S, Imai M, Tanaka H, Fuku Y, Oka N, Kato H, Yamamoto H, Fujii S, Goto T, Mitsudo K. Optical coherence tomography findings in lesions aftersirolimus-eluting stent implantation with peri-stent contrast staining. Circ Cardiovasc Interv 2012; 5: 649-656. Go to original source... Go to PubMed...
  9. Radu MD, Raber L, Kalesan B, Muramatsu T, Kelbaek H, Heo J, J?rgensen E, Helqvist S, Farooq V, Brugaletta S, Garcia-Garcia HM, Juni P, Saunamaki K, Windecker S, Serruys PW. Coronary evaginations are associated with positive vessel remodelling and are nearly absent following implantation of newer-generation drug-eluting stents: an optical coherence tomography and intravascular ultrasound study. Eur Heart J 2014; 35: 795-807. Go to original source... Go to PubMed...
  10. Hong SJ. Kim BK, Shin DH, Kim JS, KO YG, Choid D, Jan Y, Hong MK. Impact of coronary plaque chracteristics on late stent malapposition after drug-eluting stent implantation. Yonsei Med J 2015; 56: 1538-1544. Go to original source... Go to PubMed...
  11. van der Hoeven BL, Liem SS, Dijkstra J, Bergheanu SC, Putter H, Antoni ML, Atsma DE, Bootsma M, Zeppenfeld K, Jukema JW, Schalij MJ. Stent malapposition after sirolimus-eluting and bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: acute and 9-month intravascular ultrasound results of the MISSION! intervention study. JACC Cardiovasc Interv 2008; 1: 192-201. Go to original source... Go to PubMed...
  12. Karalis I, Ahmed T, Jukema JW. Late acquired stent malapposition: why, when and how to handle? Heart 2012; 98: 1529-1536. Go to original source... Go to PubMed...
  13. Kovarnik T, Mintz GS, Sonka M. The late stent malapposition develops also after paclitaxel balloon predilatation before bare-metal stent implantation: case description. Eur Heart J. 2011; 2: 1432. Go to original source... Go to PubMed...
  14. Yumoto K, Watanabe T, Fukuzawa T, Hanaki Y, Aoki H, Kato K. Development of Late Stent Malapposition After Paclitaxel-Coated Balloon Angioplasty for In-Stent Neoatherosclerosis. JACC CVI 2015; 8: e167-e169. Go to original source... Go to PubMed...
  15. Gomez-Lara J, Brugaletta S, Diletti R, Garg S, Onuma Y, Gogas BD, van Geuns RJ, Dorange C, Veldhof S, Rapoza R, Whitbourn R, Windecker S, Garcia-Garcia HM, Regar E, Serruys PW. A comparative assessment by optical coherence tomography of the performance of the first and second generation of the everolimus-eluting bioresorbable vascular scaffolds. Eur Heart J. 2011; 32: 294-304. Go to original source... Go to PubMed...
  16. Chechi T, Vecchio S, Lilli A, Giuliani G, Spaziani G, Baldereschi G, Montereggi A, Rubboli A, Margheri M. Mechanisms of late stent malapposition after primary stenting in ST-elevation myocardial infarction: a subanalysis of the selection trial. J Interv Cardiol. 2009; 22: 201-206. Go to original source... Go to PubMed...
  17. Gomez-Lara J, Radu M, Brugaletta S, Farooq V, Diletti R, Onuma Y, Windecker S, Thuesen L, McClean D, Koolen J, Whitbourn R, Dudek D, Smits PC, Regar E, Veldhof S, Rapoza R, Ormiston JA, Garcia-Garcia HM, Serruys PW. Serial analysis of the malapposed and uncovered struts of the new generation of everolimus-eluting bioresorbable scaffold with optical coherence tomography. JACC Cardiovasc Interv. 2011; 4: 992-1001. Go to original source... Go to PubMed...
  18. Cook S, Ladich E, Nakazawa G, Eshtehardi P, Neidhart M, Vogel R, Togni M, Wenaweser P, Billinger M, Seiler C, Gay S, Meier B, Pichler WJ, Juni P, Virmani R, Windecker S. Correlation of intravascular ultrasound findings with histopathological analysis of thrombus aspirates in patients with very late drug-eluting stent thrombosis. Circulation. 2009; 120: 391-399. Go to original source... Go to PubMed...
  19. Finn AV, Joner M, Nakazawa G, Kolodgie F, Newell J, John MC, Gold HK, Virmani R. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation. 2007; 115: 2435-2441. Go to original source... Go to PubMed...
  20. Lee R, Foin N, Ng J, Allen J, Soh N, Ang I, Shim W, Torii R, Wong P. Eatry coverage of drug-eluting stents analyzed by optical coherence tomography: evidence of the impact of stent apposition and strut characteristics on the neointimal healing proces. Eurointervention 2016; 12: e605-e614. Go to original source... Go to PubMed...
  21. O'Brien C, Lopez AC, Kolandaivelu K, Kunio M, Brown J, Kolachalama VB, Conway C, Bailey L, Markham P, Costa M, Ware J, EdelmanER. Vascular response to expertimental stent malapposition and under-expansion. Annals of Biomedical Engineering 2016; 44: 2251-2260. Go to original source... Go to PubMed...
  22. Gutierrez-Chico JL, Wykrzykowska JJ, Nüesch E, van Geuns RJ, Koch KT, Koolen JJ, di Mario C, Windecker S, van Es GA, Gobbens P, Jüni P, Regar E, Serruys PW. Vascular tissue reaction to acute malapposition in human coronary arteries: sequential assessment with optical coherence tomography. Circ Cardiovasc Interv. 2012; 5: 20-29. Go to original source... Go to PubMed...
  23. Gutiérrez-Chico JL, Gijsen F, Regar E, Wentzel J, De Bruyne B, Thuesen L, Ormiston J, McClean DR, Windecker S, Chevalier B, Dudek D, Whitbourn R, Brugaletta S, Serruys PW. Differences in neointimal thickness between the adluminal and the abluminal sides of malapposed and side-branch struts: evidence in vivo about the abluminal healing process. JACC Cardiovasc Interv. 2012; 5: 428-435. Go to original source... Go to PubMed...
  24. Iannaccone M, D'Ascenzo F, Templin Ch, Omede P, Montefusco A, Gaugliumi G, Serruys PW, Di Mario C, Kochman J, Quadri G, Biondi-Zoccai G, Luscher TF, Moretti C, D'amico M, Gaita F, Stone GW. Optical coherence tomography evaluation of intermediate-term healing of different stent types: systemic review and meta-analysis. EHJ Cardiovasc Imaging 20016 ahead of print, di: 10.1093/ehjci/jewD70.
  25. Steinberg DH, Mintz GS, Mandinov L, Yu A, Ellis SG, Grube E. Long-term impact of routinely detected early and late incomplete stents apposition: an integrated intravascular ultrasound analysis of the TAXUS IV, V, and VI and TAXUS ATLAS workhorse, long lesion, and direct stent studies. JACC CVI 2010; 3: 486-489. Go to original source...
  26. Sousa C, Mintz GS, Witzenbichler B, Metzger Ch, Rinaldi M, Duffy P, Weisz G, Mazzaferri E, Stuckey T, Berodie B, Xu K, Kirtane A. Stone G, Maehara A. Long-term clinical impact of acute stent malappositoin: an ADAPT-DES IVUS substudy. JACC 2014; 63: 12_S, doi: 10.1016/S0735-1097(14)61675-2. Go to original source... Go to PubMed...
  27. Cook S, Wenaweser P, Togni M, Billinger M, Morger C, Seiler C, Vogel R, Hess O, Meier B, Windecker S. Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation. Circulation 2007; 115: 2426-2436. Go to original source... Go to PubMed...
  28. Hassan AK, Bergheanu SC, Stijnen T, van der Hoeven BL, Snoep JD, Plevier JW, Schalij MJ, Wouter Jukema J. Late stent malapposition risk is higher after drug-eluting stent compared with bare-metal stent implantation and associates with late stent thrombosis. European Heart Journal 2010; 31: 1172-1180. Go to original source... Go to PubMed...
  29. Souteyrand G, Amabile N, Mangin L, Chabin X, Meneveau N, Cayla G, Vanzetto G, Barnay P, Trouillet C, Rioufol G, Range G, Teiger E, Delaunay R, Dubreuil O, Lhermusier T, Mulliez A, Levesque S, Belle L, Caussin C, Motreff P. Mechanism of stent thrombosis analysed by optical coherence tomography: insights from the national PESTO French registry. Eur Heart J. 2016; 37: 1208-1216. Go to original source... Go to PubMed...
  30. Prati F, Kodama T, Romagnoli E, Gatto L, Di Vito L, Ramazzotti V, Chisari A, Marco V, Cremonesi A, Parodi G, Albertucci M, Alfonso F. Suboptimal stent deployment is associated with subacute stent thrombosis: optical coherence tomography insights from a multicenter matched study. From the CLI Foundation investigators: the CLI-THRO study. Am Heart J. 2015; 169: 249-256 Go to original source... Go to PubMed...
  31. Ozaki Y, Okumura M, Ismail TF, Naruse H, Hattori K, Kan S, Ishikawa M, Kawai T, Takagi Y, Ishii J, Prati F, Serruys PW. The fate of inclomplte stent apposition with drug-elitng stents: an optical coherence tomoraohy-baysed natural history study. Eur. Heart J. 2010; 31: 1470-1476. Go to original source... Go to PubMed...
  32. Bhindi R, Kajander OA, Jolly SS, Kassam S, Lavi S, Niemela K, Fung A, Cheema AN, Meeks B, Alexopoulos D, Kocka V, Cantor WJ, Kaivosoja TP, Shestakovska O, Gao P, Stankovic G, Dzavik v, Sheth T. Culprit lesion thrombus burden after manual thrombectomy or percutaneous coronary intervention-alone in ST - segment elevation myocardial infarction: the optical coherence tomography sub-study of the TOTAL (ThrOmbecTomy versus PCI Alone) trial. Eur Heart J. 2015; 36: 1892-1900. Go to original source... Go to PubMed...
  33. Bouki KP, Vlad D, Riga M, Stergiouli I, Toutouzas K. Improved vascular healing after the succesful treatment of very late sirolimus-eluting stent thrombosis with a bare metal stebnt implantatin - a serial optical coherence tomography study. Hellenic journal of cardiology 2016; 57: 129-133. Go to original source... Go to PubMed...
  34. Sijde JN, Guagliumi G, Sirbu V, Shimamura K, Borghesi M, Karanasos A, regar E. The OPTIS integrated system: real-time, co-registration of angiography and optical coherence tomography. Eurointervention 2016; 12: 855-860. Go to original source... Go to PubMed...




Interventional Cardiology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.